Cost-effectiveness of inactivated influenza vaccination in children with medical risk conditions in the Netherlands

Steffie Naber, P Bruijning-Verhagen, MLA de Hoog, A Giessen

Research output: Contribution to journal › Article › Academic › peer-review

1 Citation (Scopus)

32 Downloads (Pure)

Research programs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{abfc6434b5e64227951af07ee514be0a,

title = "Cost-effectiveness of inactivated influenza vaccination in children with medical risk conditions in the Netherlands",

author = "Steffie Naber and P Bruijning-Verhagen and \{de Hoog\}, MLA and A Giessen",

year = "2020",

doi = "10.1016/j.vaccine.2020.01.057",

language = "English",

volume = "38",

pages = "3387--3396",

journal = "Vaccine",

issn = "0264-410X",

publisher = "Elsevier Ltd.",

number = "17",

}

TY - JOUR

T1 - Cost-effectiveness of inactivated influenza vaccination in children with medical risk conditions in the Netherlands

AU - Naber, Steffie

AU - Bruijning-Verhagen, P

AU - de Hoog, MLA

AU - Giessen, A

PY - 2020

Y1 - 2020

U2 - 10.1016/j.vaccine.2020.01.057

DO - 10.1016/j.vaccine.2020.01.057

M3 - Article

C2 - 32115297

SN - 0264-410X

VL - 38

SP - 3387

EP - 3396

JO - Vaccine

JF - Vaccine

IS - 17

ER -